Literature DB >> 16076348

Vitamin D for health and in chronic kidney disease.

Michael F Holick1.   

Abstract

Vitamin D is taken for granted and is not appreciated for its importance in overall health and well-being. Vitamin D, known as the sunshine vitamin, is appreciated as being important for the prevention of rickets in children. It is now recognized that vitamin D is important for not only the growing skeleton, but for the maintenance of a healthy musculoskeletal system throughout life. Vitamin D deficiency in adults precipitates and exacerbates osteoporosis and causes the painful bone disease osteomalacia. The revelation that vitamin D is biologically inactive and requires sequential hydroxylations in the liver and kidney to form 1,25-dihydroxyvitamin D helps explain why patients with renal failure are often resistant to vitamin D and suffer from secondary hyperparathyroidism and renal osteodystrophy. In addition to its role in maintaining calcium and phosphorus homeostasis, vitamin D is now being recognized as important for maintaining maximum muscle strength and for the prevention of many chronic diseases, including type I diabetes, multiple sclerosis, rheumatoid arthritis, hypertension, cardiovascular heart disease, and many common cancers. Vitamin D status is best determined by the measurement of circulating levels of 25-hydroxyvitamin D. Vigilance for maintaining a 25-hydroxyvitamin D level of at least 20 ng/ml and preferably 30-50 ng/ml has important benefits for both healthy children and adults, as well as children and adults suffering from chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076348     DOI: 10.1111/j.1525-139X.2005.18402.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  42 in total

Review 1.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

2.  A new sensitive LC/MS/MS analysis of vitamin D metabolites using a click derivatization reagent, 2-nitrosopyridine.

Authors:  Debin Wan; Jun Yang; Bogdan Barnych; Sung Hee Hwang; Kin Sing Stephen Lee; Yongliang Cui; Jun Niu; Mitchell A Watsky; Bruce D Hammock
Journal:  J Lipid Res       Date:  2017-02-01       Impact factor: 5.922

Review 3.  Disorders involving calcium, phosphorus, and magnesium.

Authors:  Sharon M Moe
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

4.  Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001-2004 NHANES.

Authors:  L H Soderstrom; S P Johnson; V A Diaz; A G Mainous
Journal:  Diabet Med       Date:  2012-01       Impact factor: 4.359

5.  Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease.

Authors:  Jessica Kendrick; Alfred K Cheung; James S Kaufman; Tom Greene; William L Roberts; Gerard Smits; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2012-05-22       Impact factor: 8.860

6.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Authors:  Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

7.  Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation.

Authors:  Rachael M Biancuzzo; Nigel Clarke; Richard E Reitz; Thomas G Travison; Michael F Holick
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

8.  1,25-Dihydroxy vitamin D and coronary microvascular function.

Authors:  Selene Capitanio; Gianmario Sambuceti; Massimo Giusti; Silvia Morbelli; Giovanni Murialdo; Giacomo Garibotto; Lara Vera; Pietro Ameri; Barbara Repetto; Mehrdad Naseri; Irene Bossert; Maria Teresa Verardi; Michela Massollo; Cecilia Marini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

9.  Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.

Authors:  Pieter Evenepoel; Bjorn K I Meijers; Hylke de Jonge; Maarten Naesens; Bert Bammens; Kathleen Claes; Dirk Kuypers; Yves Vanrenterghem
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

10.  VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome.

Authors:  Ursula Thiem; Georg Heinze; Rudolf Segel; Thomas Perkmann; Franz Kainberger; Ferdinand Mühlbacher; Walter Hörl; Kyra Borchhardt
Journal:  Trials       Date:  2009-05-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.